ReviewCureus2025
A Systematic Review of Surgical Outcomes: Comparing Robotic-Assisted Partial Nephrectomy and Open Partial Nephrectomy in Nephron-Sparing Surgery for Renal Tumors.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Feasibility and clinical outcomes of same-day discharge after robot-assisted partial nephrectomy at an ambulatory surgery center.Journal of robotic surgery · 2026Observational
- On-Clamp Versus Off-Clamp Robot-Assisted Partial Nephrectomy for Localized Renal Tumors: A Retrospective Single-Center Cohort Study.Diagnostics (Basel, Switzerland) · 2026Article
- QUIPS-based prospective postoperative pain assessment following nephrectomy and partial nephrectomy in robot-assisted, conventional laparoscopic, and open surgical approaches.Frontiers in surgery · 2026Article
- Same day discharge after robot assisted partial nephrectomy.World journal of urology · 2025Review
- The Influence of 3D Technology Integration on Laparoscopic Partial Nephrectomy Practice and Surgical Outcomes.Current oncology (Toronto, Ont.) · 2025Article
- Optimizing outcomes of partial nephrectomy in patients with tumors in solitary kidneys: a non-systematic review.Journal of medicine and life · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A partial nephrectomy is a critical approach for nephron-sparing surgery in renal tumors, striking a balance between oncological control and the preservation of renal function. Surgeons traditionally view open partial nephrectomy (OPN) as the gold standard in kidney surgery. The emergence of robotic-assisted partial nephrectomy (RAPN) offers a minimally invasive alternative that can improve surgical precision and decrease the risk of complications during the perioperative period. This systematic review analyzes and compares OPN and RAPN based on factors such as oncological effectiveness, preservation of kidney function, perioperative outcomes, and complication rates. We followed the 2020 Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines to review and include studies, analyzing 30 studies that involved more than 26,826 patients. The research team carried out retrospective and prospective cohort studies and randomized controlled trials (RCTs). They measured the quality of these studies by using the Newcastle-Ottawa Scale (NOS) for observational studies and the Cochrane Risk of Bias tool version 2 (RoB 2; Cochrane, London, UK) for RCTs. Our findings indicate that RAPN offers significant perioperative advantages, such as reduced mean estimated blood loss (EBL) of 181 mL compared to 284 mL for OPN and shorter hospital stays averaging three days compared to six days for OPN. Follow-up durations ranged from three to 60 months. Although the surgery for RAPN takes longer, it consistently preserves renal function better, resulting in less considerable declines in the estimated glomerular filtration rate (eGFR). Oncological outcomes show that RAPN achieves a negative surgical margin (NSM) rate of 97.16%, while OPN reaches 92%. RAPN effectively handles complex renal tumors, especially those with high Preoperative Aspects and Dimensions Used for Anatomical (PADUA) or R.E.N.A.L. Nephrometry score (Radius (R), Exophytic/Endophytic properties (E), Nearness to the collecting system or sinus (N), Anterior/Posterior location (A), Location relative to polar lines (L)). In conclusion, RAPN offers significant advantages in perioperative and functional outcomes while maintaining oncological equivalence to OPN. This seals RAPN as the preferred approach in centers with robotic expertise. However, OPN remains a viable option in low-resource settings. Future research should improve access to robotic systems, standardize reporting metrics, and conduct long-term randomized trials to understand both techniques' strengths and limitations better.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.